Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
32,270,909
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
361,326
-
Shares change
-
+278,421
-
Total reported value, excl. options
-
$1,737,881
-
Value change
-
+$1,328,649
-
Number of buys
-
19
-
Number of sells
-
4
-
Price
-
$4.81
Institutional Holders of Telomir Pharmaceuticals, Inc. - Common Stock, no par value (TELO) as of Q2 2024
As of 30 Jun 2024 Telomir Pharmaceuticals, Inc. - Common Stock, no par value (TELO) had 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 361,326 shares of stock of the company.
Largest 10 holders included BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, VANGUARD GROUP INC, Suncoast Equity Management, NEW YORK STATE COMMON RETIREMENT FUND, STATE STREET CORP, Beaird Harris Wealth Management, LLC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and CITIGROUP INC.
This table shows 24 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.